{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:51:48Z","timestamp":1778212308589,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:00:00Z","timestamp":1498348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nefrolog\u00eda"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.nefro.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T03:47:25Z","timestamp":1500522445000},"page":"638-645","source":"Crossref","is-referenced-by-count":12,"title":["Trasplante renal procedente de donante vivo HLA incompatible: Eficacia y pron\u00f3stico en 32 pacientes tras desensibilizaci\u00f3n"],"prefix":"10.1016","volume":"37","author":[{"given":"Constantino","family":"Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Ferreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roi","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Seijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefro.2017.06.006_bib0140","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensititazion protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2017.06.006_bib0145","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/TP.0000000000001330","article-title":"32 doses of bortezomib for desensitization is not well tolerated and is associated with only modest reductions in anti-HLA antibody","volume":"101","author":"Moreno Gonzales","year":"2017","journal-title":"Transplantation."},{"key":"10.1016\/j.nefro.2017.06.006_bib0150","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.05930615","article-title":"Approach to the highly sensitized kidney transplant candidate","author":"Keith","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefro.2017.06.006_bib0155","unstructured":"Programa nacional de donaci\u00f3n renal cruzada. Version 6.0. [consultado 25 Abr 2015] Disponible en: http:\/\/www.ont.es\/infesp\/Paginas\/DocumentosdeConsenso.aspx."},{"key":"10.1016\/j.nefro.2017.06.006_bib0160","unstructured":"PATHI. Programa de acceso trasplante de hiperinmunizados Protocolo basado en prueba cruzada virtual. ONT [consultado 7 Jun 2016]. Disponible en: http:\/\/www.ont.es\/infes\/DocumentosDeConsenso\/PROTOCOLO%PATHI.pdf."},{"key":"10.1016\/j.nefro.2017.06.006_bib0165","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1681\/ASN.2015080934","article-title":"Early changes in kidney distribution under the new allocation system","volume":"27","author":"Massie","year":"2016","journal-title":"J Am Soc Nephrol. Publised online ahead of print"},{"key":"10.1016\/j.nefro.2017.06.006_bib0170","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"New Eng J Med"},{"key":"10.1016\/j.nefro.2017.06.006_bib0175","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ctr.12335","article-title":"Desensitization in kidney transplantation: Review and future perspectives","volume":"28","author":"Jawdeh","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.nefro.2017.06.006_bib0180","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/01.TP.0000442782.98131.7c","article-title":"Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch","volume":"97","author":"Riella","year":"2014","journal-title":"Transplantation"},{"issue":"Sup2","key":"10.1016\/j.nefro.2017.06.006_bib0185","first-page":"p156","article-title":"PRA (Panel reactive antibodies) pretrasplante: Valor pron\u00f3stico en trasplante renal","volume":"33","author":"Fern\u00e1ndez","year":"2013","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.nefro.2017.06.006_bib0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 Meeting Report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2017.06.006_bib0195","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/ajt.13661","article-title":"The revised (2013) Banff classification for antibody-mediated rejection of renal allografts: Update, difficulties, and future considerations","volume":"16","author":"Haas","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2017.06.006_bib0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.nefro.2017.06.006_bib0205","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"New Eng J Med"},{"key":"10.1016\/j.nefro.2017.06.006_bib0210","article-title":"Renal transplantation across the donor specific antibody barrier: Graft outcome and cancer risk after desensitization therapy","author":"Yang","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.nefro.2017.06.006_bib0215","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.transproceed.2015.09.025","article-title":"Desensitization before living donor kidney transplantation in highly HLA sensitized patients: A single-center study","volume":"47","author":"De Sousa-Amorin","year":"2015","journal-title":"Transplant Procc"},{"key":"10.1016\/j.nefro.2017.06.006_bib0220","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/TP.0b013e3181ea3985","article-title":"An integrative approach for the transplantation of high risk sensitized patients","volume":"90","author":"Morath","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2017.06.006_bib0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2012.04291.x","article-title":"Five-year outcomes in living donor kidney transplants with a positive crossmatch","volume":"13","author":"Bental Al Cornell","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2017.06.006_bib0230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: The University of Illinois at Chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nefro.2017.06.006_bib0235","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.TP.0000438207.42465.40","article-title":"Effect of a proteosoma inhibitor plus steroids on HLA antibodies in sensitized patients awaiting a renal transplantation","volume":"97","author":"Aubert","year":"2014","journal-title":"Transplantation"},{"issue":"Suppl 5","key":"10.1016\/j.nefro.2017.06.006_bib0240","article-title":"Prospective, iterative, phased, trial of proteasome inhibitor-based desensitization in highly sensitized renal transplant candidates","volume":"13","author":"Woodle","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2017.06.006_bib0245","doi-asserted-by":"crossref","unstructured":"Kauke T, Klimaschewski S, Schoenermarck U, Fischereder M, Dick A, Guba M, et al. Outcome after desensitization in HLA or ABO-incompatible kidney transplant recipients: A single center experience. Plos One. DOI: 10.1371\/journal.pone.0146075.","DOI":"10.1371\/journal.pone.0146075"},{"key":"10.1016\/j.nefro.2017.06.006_bib0250","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nefro.2017.06.006_bib0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"New Eng J Med"},{"key":"10.1016\/j.nefro.2017.06.006_bib0260","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tri.12447","article-title":"How can we minimize bleeding complications in ABO-incompatible kidney transplant recipients?","volume":"28","author":"Ohdan","year":"2015","journal-title":"Transplant Int"},{"key":"10.1016\/j.nefro.2017.06.006_bib0265","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tri.12469","article-title":"Adquired factor XIII deficiency after desensitization as a potential contributor to postoperative bleeding: Mare than meets the eye","volume":"28","author":"Focosi","year":"2015","journal-title":"Transplant Int"},{"key":"10.1016\/j.nefro.2017.06.006_bib0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tri.12412","article-title":"ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen\u2013specific immunoadsorption","volume":"28","author":"De Weerd","year":"2015","journal-title":"Transplant Int"}],"container-title":["Nefrolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699517301443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0211699517301443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T17:09:33Z","timestamp":1530032973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0211699517301443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0211699517301443"],"URL":"https:\/\/doi.org\/10.1016\/j.nefro.2017.06.006","relation":{},"ISSN":["0211-6995"],"issn-type":[{"value":"0211-6995","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}